SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-017739
Filing Date
2022-03-09
Accepted
2022-03-09 20:45:04
Documents
1
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17735
  Complete submission text file 0001209191-22-017739.txt   19105
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Schroeder Thilo (Reporting) CIK: 0001776412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 22727137